Rubicon Research share price dips after strong listing. Should investors buy, sell or hold this pharma stock?

Rubicon Research share price fell over 1% despite a strong market debut, opening at ₹620, up 27.83% from its issue price. The IPO was oversubscribed 103.90 times, raising ₹1,377.5 crore, with funds earmarked for debt and acquisitions.

Markets